Charlottesville, VA, United States of America

Inchan Kwon

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inchan Kwon. Retrieved from https://idiyas.com/inventor/inchan-kwon-m488l071

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inchan Kwon: Innovator in Cell Culture Technology

Introduction

Inchan Kwon is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of cell culture technology, holding 2 patents that focus on innovative methods for preparing poloxamers for use in cell culture media.

Latest Patents

Kwon's latest patents include methods of preparing a poloxamer for use in cell culture medium. These patents provide detailed methodologies for creating poloxamer that can be utilized in cell culture media. Additionally, they describe the use of these media for cell culturing and polypeptide production from cells.

Career Highlights

Throughout his career, Inchan Kwon has worked with prominent companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his expertise in the field of biotechnology.

Collaborations

Some of Kwon's notable coworkers include Ganesh Prasadh Vissvesvaran and Robert David Kiss. Their collaborative efforts have contributed to advancements in the technologies related to cell culture.

Conclusion

Inchan Kwon's work in developing methods for preparing poloxamers has made a significant impact on cell culture technology. His contributions continue to influence the field and enhance the capabilities of researchers and scientists.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…